期刊文献+

儿童非霍奇金淋巴瘤MDM2和p53蛋白表达的研究 被引量:1

Relationship between the expression of MDM2 protein, p53 protein and non-Hodgkin lymphoma in childhood
原文传递
导出
摘要 目的探讨儿童非霍奇金淋巴瘤(NHL)患者癌基因MDM2和抑癌基因p53的表达与NHL的恶性程度和预后的关系。方法46例儿童NHL患者作为病例组,12例儿童淋巴结炎患者作为对照组。用免疫组织化学超敏S-P染色法,检测病例组NHL患者、对照组淋巴结炎患者病理组织的MDM2蛋白和p53蛋白的表达情况,阳性细胞为胞核染成黄色 ̄棕黄色,阳性细胞数≥10%为MDM2免疫组织化学阳性(MDM2蛋白过度表达);阳性细胞数>5%为p53免疫组织化学阳性。结果病例组MDM2蛋白过度表达率为65.2%,与对照组比较差异有统计学意义(P<0.01)。p53蛋白阳性率为19.6%,与对照组比较差异无统计学意义(P>0.05)。MDM2蛋白过度表达率在病理分类高度恶性、患者血清LDH增高之间差异均有统计学意义(P<0.05),与患者的B状态间差异有统计学意义(P<0.01)。p53蛋白阳性率在病理工作分类、临床分期、B状态、血清LDH之间差异均无统计学意义(P>0.05)。MDM2蛋白过度表达与p53蛋白阳性之间没有关联性。结论儿童NHL患者MDM2基因的过度表达率较高;MDM2过度表达与儿童NHL患者的不良状况、不良预后有关;儿童NHL患者p53阳性率较低。 Objective To investigate the relationship between the expression of MDM2 protein, p53 protein and the malignant grade as well as prognosis of non-Hodgkin lymphoma(NHL) in childhood. Methods 46 cases of NHL were chosen as patient group and 12 cases of lymphadenitis as control group. Immunohistochmistry ultrasensitive S-P assay was used to detect the expression of MDM2 protein and p53 protein in pathological tissues in all cases. Positive cells were dyed yellow or brown in nuclei. Positive MDM2 was that the p...
出处 《白血病.淋巴瘤》 CAS 2006年第4期252-254,共3页 Journal of Leukemia & Lymphoma
基金 广西壮族自治区科学基金资助项目(桂科基0342010-8)
关键词 非霍奇金淋巴瘤 癌基因MDM2 抑癌基因P53 预后 MDM2 protein p53 protein Prognosis Non-Hodgkin lymphoma
  • 相关文献

参考文献1

二级参考文献4

  • 1Momand J, Wu HH, Dasgupta G. MDM2-master regulator of the tumor suppressor protein . Gene, 2000, 242(1-2):15-29.
  • 2Bueso-Ramos CE, Yang Y, Deleon E, et al. The human MDM-2 oncogene is overexpressed in leukemias. Blood, 1993, 82:2617-2623.
  • 3Moller MB, Nielsen O, Pedersen T, et al. Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkins Lymphoma entities. Mod Pathol, 1999, 12:1010-1016.
  • 4Moller MB, lno Y, Gerdes AM, et al. Aberrations of the p53 pathway components p53, MDM2, and CDKN2A appear independent in diffuse large B-cell lymphoma. Lcukemia, 1999, 13:453-459.

共引文献2

同被引文献9

  • 1OlinerJD,Kinzler KW,Meltzer P S,et al.Amplification of a gene encoding a p53-associatd protein in human sarcomas.Nature,1992,358:80-83.
  • 2Momand J,Zambetti G P,Olson DC,et al.The mdm2 oncogen product forms a complex with the p53 protein and inhibits p53 mediated transactivation.Cell,1992,69:1237-1245.
  • 3Marks DI,Kurz BE,Link MP,et al.High incidence of potential p53 inactivation in poor outcome childhood acute leukemia at diagnosis.Blood,1996,87:1155-1161.
  • 4Wawrzynow B,Zylira A,Wallace M,et al.MDM2 nhaperones the p53 tumor suppressor.J Biol Chem,2007,282:32603-32612.
  • 5Mendrysa SM,O'Leary KA,McElwee MK,et al.Tumor suppression and normal aging in mice with constitutively high p53 activity.Genes Dev,2006,20:16-21.
  • 6Moller MB,Nielsen 0,Pedersen T,et al.Oncoprotein MDM2 over expression is associated with poor prognosis in distinct non-Hodgkin's lymphoma entities.Mod Pathol,1999,12:1010-1016.
  • 7Rayburn E,Zhang E,He J,et al.MDM2 and human malignancies:expression,clinical pathology,prognostic markers,and implications for chemotherapy.Cur Cancer Drug Targets,2005,5:27-41.
  • 8Gu L,Findly HW,Zhou M.mdm2 induces NF-kappa B/p65 expression transcriptional through Sp-1-binding sites:a novel,p53independent role of mdm2 in doxorubicin resistance in acute lymphoblastic leukemia.Blood,2002,52:3367-3375.
  • 9蒋莎义,陈力军,高飞,李桂梅,刘廷亮,尹洪臣.癌基因MDM2过度表达与儿童急性淋巴细胞白血病的发病和预后的关系[J].中华儿科杂志,2000,38(7):445-445. 被引量:4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部